Literature DB >> 26722432

MicroRNA-592 targets DEK oncogene and suppresses cell growth in the hepatocellular carcinoma cell line HepG2.

Xin Li1, Wenfeng Zhang1, Liya Zhou1, Donghui Yue1, Xin Su1.   

Abstract

MicroRNAs (miRNAs) are classes of small, non-coding RNAs that regulate the translation of target mRNA transcripts. In this study, we demonstrated that miR-592 was downregulated in human hepatocellular carcinoma (HCC) and could suppress growth of the human HCC cell line HepG2. A tumor oncogene, DEK, was identified as a direct target of miR-592. Luciferase report assay indicated miR-592 regulates DEK expression though bind to its 3'UTR. Furthermore, knockdown of DEK also suppressed cell proliferation of HepG2 cells, which was consist with miR-592. At last, we suggested that DEK was upregulated in HCC tissues inversely with miR-592. These results demonstrated that miR-592 targets DEK transcript and suppresses HCC cell growth, and may provide potential therapeutic target in human HCC.

Entities:  

Keywords:  DEK; cell growth; hepatocellular carcinoma; miR-592

Mesh:

Substances:

Year:  2015        PMID: 26722432      PMCID: PMC4680377     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  22 in total

1.  Intron removal requires proofreading of U2AF/3' splice site recognition by DEK.

Authors:  Luis Miguel Mendes Soares; Katia Zanier; Cameron Mackereth; Michael Sattler; Juan Valcárcel
Journal:  Science       Date:  2006-06-30       Impact factor: 47.728

2.  Widespread changes in protein synthesis induced by microRNAs.

Authors:  Matthias Selbach; Björn Schwanhäusser; Nadine Thierfelder; Zhuo Fang; Raya Khanin; Nikolaus Rajewsky
Journal:  Nature       Date:  2008-07-30       Impact factor: 49.962

3.  MiR-378 controls cardiac hypertrophy by combined repression of mitogen-activated protein kinase pathway factors.

Authors:  Jayavarshni Ganesan; Deepak Ramanujam; Yassine Sassi; Andrea Ahles; Claudia Jentzsch; Stanislas Werfel; Simon Leierseder; Xavier Loyer; Mauro Giacca; Lorena Zentilin; Thomas Thum; Bernhard Laggerbauer; Stefan Engelhardt
Journal:  Circulation       Date:  2013-04-26       Impact factor: 29.690

4.  Identification and characterization of genes associated with human hepatocellular carcinogenesis.

Authors:  N Kondoh; T Wakatsuki; A Ryo; A Hada; T Aihara; S Horiuchi; N Goseki; O Matsubara; K Takenaka; M Shichita; K Tanaka; M Shuda; M Yamamoto
Journal:  Cancer Res       Date:  1999-10-01       Impact factor: 12.701

5.  MicroRNA signatures in human ovarian cancer.

Authors:  Marilena V Iorio; Rosa Visone; Gianpiero Di Leva; Valentina Donati; Fabio Petrocca; Patrizia Casalini; Cristian Taccioli; Stefano Volinia; Chang-Gong Liu; Hansjuerg Alder; George A Calin; Sylvie Ménard; Carlo M Croce
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

6.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.

Authors:  Nozomu Yanaihara; Natasha Caplen; Elise Bowman; Masahiro Seike; Kensuke Kumamoto; Ming Yi; Robert M Stephens; Aikou Okamoto; Jun Yokota; Tadao Tanaka; George Adrian Calin; Chang-Gong Liu; Carlo M Croce; Curtis C Harris
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

7.  MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin.

Authors:  Tao Liu; Hua Tang; Yuanyuan Lang; Min Liu; Xin Li
Journal:  Cancer Lett       Date:  2008-09-13       Impact factor: 8.679

8.  Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target.

Authors:  Yu Wang; Alvin T C Lee; Joel Z I Ma; Jingbo Wang; Jianwei Ren; Yuchen Yang; Erwin Tantoso; Kuo-Bin Li; London L P J Ooi; Patrick Tan; Caroline G L Lee
Journal:  J Biol Chem       Date:  2008-03-04       Impact factor: 5.157

9.  Forced expression of the DEK-NUP214 fusion protein promotes proliferation dependent on upregulation of mTOR.

Authors:  Carl Sandén; Malin Ageberg; Jessica Petersson; Andreas Lennartsson; Urban Gullberg
Journal:  BMC Cancer       Date:  2013-09-27       Impact factor: 4.430

10.  The DEK oncogene is a target of steroid hormone receptor signaling in breast cancer.

Authors:  Lisa M Privette Vinnedge; Shuk-Mei Ho; Kathryn A Wikenheiser-Brokamp; Susanne I Wells
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

View more
  6 in total

1.  MiR-138-5p Inhibits the Proliferation of Gastric Cancer Cells by Targeting DEK.

Authors:  Wei Zhang; Kai Liao; Dongning Liu
Journal:  Cancer Manag Res       Date:  2020-09-08       Impact factor: 3.989

2.  Dek overexpression in murine epithelia increases overt esophageal squamous cell carcinoma incidence.

Authors:  Marie C Matrka; Katherine A Cimperman; Sarah R Haas; Geraldine Guasch; Lisa A Ehrman; Ronald R Waclaw; Kakajan Komurov; Adam Lane; Kathryn A Wikenheiser-Brokamp; Susanne I Wells
Journal:  PLoS Genet       Date:  2018-03-14       Impact factor: 5.917

3.  Expression of DEK in pancreatic cancer and its correlation with clinicopathological features and prognosis.

Authors:  Ting Zhao; Bijun Qiu; Senhao Zhou; Guoping Ding; Liping Cao; Zhengrong Wu
Journal:  J Cancer       Date:  2019-01-29       Impact factor: 4.207

4.  Somatic Mutations in miRNA Genes in Lung Cancer-Potential Functional Consequences of Non-Coding Sequence Variants.

Authors:  Paulina Galka-Marciniak; Martyna Olga Urbanek-Trzeciak; Paulina Maria Nawrocka; Agata Dutkiewicz; Maciej Giefing; Marzena Anna Lewandowska; Piotr Kozlowski
Journal:  Cancers (Basel)       Date:  2019-06-08       Impact factor: 6.639

5.  Construction of a Necroptosis-Related miRNA Signature for Predicting the Prognosis of Patients With Hepatocellular Carcinoma.

Authors:  Tongyu Meng; Qingfeng Wang; Yufeng Yang; Yanling Ren; Yan Shi
Journal:  Front Genet       Date:  2022-04-12       Impact factor: 4.772

6.  Automated detection of ncRNAs in the draft genome sequence of a colonial tunicate: the carpet sea squirt Didemnum vexillum.

Authors:  Cristian A Velandia-Huerto; Adriaan A Gittenberger; Federico D Brown; Peter F Stadler; Clara I Bermúdez-Santana
Journal:  BMC Genomics       Date:  2016-08-30       Impact factor: 3.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.